Rethinking publication bias: from mechanical correction to sensitivity-based interpretation
Article information
Recently, the medical community has intensified efforts to improve the reliability of meta-analyses. Among the various threats to validity, a major source of distortion in clinical evidence remains publication bias, whereby studies with positive findings are preferentially published.
In this issue of the Korean Journal of Anesthesiology, Kang [1] presents a comprehensive review entitled “Correcting what cannot be corrected: rethinking publication bias analysis methods in clinical meta-analyses,” which critically challenges the prevailing practice of mechanically “correcting” publication bias using statistical tools. Instead, the author advocates a transition toward a more structured and conceptually grounded analytical framework [1].
Traditionally, the field has assumed that asymmetry in funnel plots or the application of mathematical approaches such as trim-and-fill could identify missing studies and reconstruct an underlying “true effect” [2]. However, through reanalysis of clinical datasets, including studies on antiemetic efficacy, Kang [1] demonstrates that even minor variations in statistical assumptions can lead to substantial shifts in estimated effects, ranging from “highly effective” to “ineffective”. These findings underscore that statistical techniques are not curative solutions for bias. Rather, they function as stress tests that expose the fragility of the available evidence. Accordingly, the author emphasizes a shift from seeking a single corrected estimate to conducting structured sensitivity analyses to evaluate the robustness of conclusions under varying assumptions.
This perspective aligns closely with the conceptual framework of heterogeneity articulated in the author’s previous work [3,4]. Clinical studies inherently differ with respect to patient populations, comorbidities, institutional settings, and procedural techniques. When bias is suspected, disentangling selective non-publication from genuine between-study differences is often not feasible. Therefore, the implicit assumption that treatment effects are homogeneous across diverse clinical contexts is untenable. A more defensible approach would be to explicitly acknowledge and incorporate this inherent heterogeneity into the analyses and interpretations.
The evolving landscape of scientific publishing further complicates bias control. The rapid expansion of non-peer-reviewed preprints increases the likelihood of preliminary unverified findings entering the evidence ecosystem without adequate scrutiny. In umbrella reviews, which synthesize multiple systematic reviews, the duplication of primary studies can lead to vertical inflation of effect estimates. For example, if a single randomized trial evaluating the reversal efficacy of a neuromuscular blocking agent is repeatedly included across overlapping reviews, the apparent effect size may be disproportionately amplified. In addition, emerging artificial-intelligence-driven search and synthesis systems may preferentially learn from highly cited yet potentially biased datasets, generating authoritative outputs that obscure the underlying evidentiary limitations. These developments necessitate a more rigorous and critical appraisal framework.
In conclusion, the standards for conducting and evaluating meta-analyses require substantive reconsideration. Reliance on checklist-based reporting alone is insufficient; instead, a transparent acknowledgment of data limitations must be prioritized. The application of multifaceted analytical approaches, including Bayesian frameworks, may facilitate a more nuanced visualization of how conclusions vary under alternative assumptions. From an editorial perspective, establishing explicit criteria for identifying fatal methodological flaws may be necessary to preserve scientific rigor. Three considerations merit particular attention. First, conclusions that attribute funnel plot asymmetry or statistical detection results solely to publication bias without adequately accounting for heterogeneity reflect a fundamental inferential error. Second, the absence of structured sensitivity analyses coupled with an uncritical reliance on a single adjusted estimate undermines the credibility of the reported findings. Third, manuscripts that present definitive clinical recommendations without appropriately downgrading the certainty of evidence despite recognized data limitations risk misleading readers and should be critically scrutinized.
Notes
Funding
None.
Conflicts of Interest
Sangseok Lee is the Editor-in-Chief of the Korean Journal of Anesthesiology. There were no other potential conflicts of interest relevant to this article.
